Versant Venture Capital V, L.P. Transaction History

Date Transaction Value Shares Traded Form
Apr 24 2018
SELL
Open market or private sale
$1,162,607 $50.9 p/Share
22,841

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
VVC

Versant Venture Capital V, L.P.

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP